Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 Jan;152(1):219–229.

Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression.

M Trudel 1, L Barisoni 1, J Lanoix 1, V D'Agati 1
PMCID: PMC1858107  PMID: 9422539

Abstract

SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) produced by dysregulation of c-myc in the kidneys. Our previous demonstration that c-myc is overexpressed in human autosomal polycystic kidney disease (ADPKD) prompted us to investigate the pathogenetic role of c-myc in the induction and progression of the cystogenic phenotype in our mouse model. In young SBM kidneys, c-myc was two- to threefold increased with persistent expression levels into adulthood, an age when c-myc is normally undetectable. In situ hybridization analysis of the c-myc transgene demonstrated intense signal specifically overlying glomerular and tubular epithelium of developing cysts in fetal and young kidneys. Increased expression of c-myc correlated with the initiation and progression of the PKD phenotype as evidenced by early tubular and glomerular cysts at E16.5. Cyst number and size increased with age, with co-development of glomerular and tubular epithelial hyperplasia. Consistently, the mean renal proliferative index was increased approximately 5- to 20-fold in noncystic and cystic tubules of newborn SBM animals compared with littermate controls. Similarly, in fetal and newborn kidneys the tubular apoptotic indices were increased approximately three- to ninefold over controls. Both proliferation and apoptotic rates in cystic tubules approached levels in developing tubules from the normal nephrogenic zone. We conclude that the pathogenesis of PKD hinges on a critical imbalance in c-myc regulation of the opposing processes of cell proliferation and apoptosis, recapitulating the cellular phenomena in developing fetal kidney.

Full text

PDF
219

Images in this article

222Figure 1
on p.222
223Figure 2
on p.223
224Figure 3
on p.224
225Figure 4
on p.225
226Figure 5
on p.226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askew D. S., Ashmun R. A., Simmons B. C., Cleveland J. L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 1991 Oct;6(10):1915–1922. [PubMed] [Google Scholar]
  2. Barisoni L., Trudel M., Chrétien N., Ward L., van Adelsberg J., D'Agati V. Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. Am J Pathol. 1995 Dec;147(6):1728–1735. [PMC free article] [PubMed] [Google Scholar]
  3. Baylis C., Brenner B. M. Mechanism of the glucocorticoid-induced increase in glomerular filtration rate. Am J Physiol. 1978 Feb;234(2):F166–F170. doi: 10.1152/ajprenal.1978.234.2.F166. [DOI] [PubMed] [Google Scholar]
  4. Brinster R. L., Chen H. Y., Messing A., van Dyke T., Levine A. J., Palmiter R. D. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell. 1984 Jun;37(2):367–379. doi: 10.1016/0092-8674(84)90367-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burn T. C., Connors T. D., Dackowski W. R., Petry L. R., Van Raay T. J., Millholland J. M., Venet M., Miller G., Hakim R. M., Landes G. M. Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium). Hum Mol Genet. 1995 Apr;4(4):575–582. doi: 10.1093/hmg/4.4.575. [DOI] [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Coles H. S., Burne J. F., Raff M. C. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development. 1993 Jul;118(3):777–784. doi: 10.1242/dev.118.3.777. [DOI] [PubMed] [Google Scholar]
  8. D'Agati V., Trudel M. Lectin characterization of cystogenesis in the SBM transgenic model of polycystic kidney disease. J Am Soc Nephrol. 1992 Oct;3(4):975–983. doi: 10.1681/ASN.V34975. [DOI] [PubMed] [Google Scholar]
  9. Daoust M. C., Reynolds D. M., Bichet D. G., Somlo S. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics. 1995 Feb 10;25(3):733–736. doi: 10.1016/0888-7543(95)80020-m. [DOI] [PubMed] [Google Scholar]
  10. Eulderink F., Hogewind B. L. Renal cysts in premature children: occurrence in a family with polycystic kidney disease. Arch Pathol Lab Med. 1978 Nov;102(11):592–595. [PubMed] [Google Scholar]
  11. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992 Apr 3;69(1):119–128. doi: 10.1016/0092-8674(92)90123-t. [DOI] [PubMed] [Google Scholar]
  12. Evan G., Harrington E., Fanidi A., Land H., Amati B., Bennett M. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond B Biol Sci. 1994 Aug 30;345(1313):269–275. doi: 10.1098/rstb.1994.0105. [DOI] [PubMed] [Google Scholar]
  13. Geng L., Segal Y., Peissel B., Deng N., Pei Y., Carone F., Rennke H. G., Glücksmann-Kuis A. M., Schneider M. C., Ericsson M. Identification and localization of polycystin, the PKD1 gene product. J Clin Invest. 1996 Dec 15;98(12):2674–2682. doi: 10.1172/JCI119090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ibraghimov-Beskrovnaya O., Dackowski W. R., Foggensteiner L., Coleman N., Thiru S., Petry L. R., Burn T. C., Connors T. D., Van Raay T., Bradley J. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6397–6402. doi: 10.1073/pnas.94.12.6397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Janaswami P. M., Birkenmeier E. H., Cook S. A., Rowe L. B., Bronson R. T., Davisson M. T. Identification and genetic mapping of a new polycystic kidney disease on mouse chromosome 8. Genomics. 1997 Feb 15;40(1):101–107. doi: 10.1006/geno.1996.4567. [DOI] [PubMed] [Google Scholar]
  16. Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., Kitamura Y., Kondoh H., Tsujimoto Y. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 1995 Jan 15;55(2):354–359. [PubMed] [Google Scholar]
  17. Kaspareit-Rittinghausen J., Deerberg F., Rapp K. G., Wcislo A. A new rat model for polycystic kidney disease of humans. Transplant Proc. 1990 Dec;22(6):2582–2583. [PubMed] [Google Scholar]
  18. Kelley K. A., Agarwal N., Reeders S., Herrup K. Renal cyst formation and multifocal neoplasia in transgenic mice carrying the simian virus 40 early region. J Am Soc Nephrol. 1991 Jul;2(1):84–97. doi: 10.1681/ASN.V2184. [DOI] [PubMed] [Google Scholar]
  19. Koseki C., Herzlinger D., al-Awqati Q. Apoptosis in metanephric development. J Cell Biol. 1992 Dec;119(5):1327–1333. doi: 10.1083/jcb.119.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lanoix J., D'Agati V., Szabolcs M., Trudel M. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene. 1996 Sep 19;13(6):1153–1160. [PubMed] [Google Scholar]
  21. MacKay K., Striker L. J., Pinkert C. A., Brinster R. L., Striker G. E. Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int. 1987 Dec;32(6):827–837. doi: 10.1038/ki.1987.283. [DOI] [PubMed] [Google Scholar]
  22. Michaud J., Russo P., Grignon A., Dallaire L., Bichet D., Rosenblatt D., Lamothe E., Lambert M. Autosomal dominant polycystic kidney disease in the fetus. Am J Med Genet. 1994 Jul 1;51(3):240–246. doi: 10.1002/ajmg.1320510314. [DOI] [PubMed] [Google Scholar]
  23. Moyer J. H., Lee-Tischler M. J., Kwon H. Y., Schrick J. J., Avner E. D., Sweeney W. E., Godfrey V. L., Cacheiro N. L., Wilkinson J. E., Woychik R. P. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science. 1994 May 27;264(5163):1329–1333. doi: 10.1126/science.8191288. [DOI] [PubMed] [Google Scholar]
  24. Mugrauer G., Ekblom P. Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J Cell Biol. 1991 Jan;112(1):13–25. doi: 10.1083/jcb.112.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nadasdy T., Laszik Z., Lajoie G., Blick K. E., Wheeler D. E., Silva F. G. Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol. 1995 Jan;5(7):1462–1468. doi: 10.1681/ASN.V571462. [DOI] [PubMed] [Google Scholar]
  26. Nakayama K., Nakayama K., Negishi I., Kuida K., Sawa H., Loh D. Y. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3700–3704. doi: 10.1073/pnas.91.9.3700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nidess R., Koch W. E., Fried F. A., McFarland E., Mandell J. Development of the embryonic murine kidney in normal and congenital polycystic kidney disease: characterization of a proximal tubular degenerative process as the first observable light microscopic defect. J Urol. 1984 Jan;131(1):156–162. doi: 10.1016/s0022-5347(17)50250-5. [DOI] [PubMed] [Google Scholar]
  28. Palmiter R. D., Chen H. Y., Messing A., Brinster R. L. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature. 1985 Aug 1;316(6027):457–460. doi: 10.1038/316457a0. [DOI] [PubMed] [Google Scholar]
  29. Perey D. Y., Herdman R. C., Good R. A. Polycystic renal disease: a new experimental model. Science. 1967 Oct 27;158(3800):494–496. doi: 10.1126/science.158.3800.494. [DOI] [PubMed] [Google Scholar]
  30. Preminger G. M., Koch W. E., Fried F. A., McFarland E., Murphy E. D., Mandell J. Murine congenital polycystic kidney disease: a model for studying development of cystic disease. J Urol. 1982 Mar;127(3):556–560. doi: 10.1016/s0022-5347(17)53911-7. [DOI] [PubMed] [Google Scholar]
  31. Pulendran B., Kannourakis G., Nouri S., Smith K. G., Nossal G. J. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature. 1995 May 25;375(6529):331–334. doi: 10.1038/375331a0. [DOI] [PubMed] [Google Scholar]
  32. Qian F., Germino F. J., Cai Y., Zhang X., Somlo S., Germino G. G. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet. 1997 Jun;16(2):179–183. doi: 10.1038/ng0697-179. [DOI] [PubMed] [Google Scholar]
  33. Rentrop M., Knapp B., Winter H., Schweizer J. Aminoalkylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions. Histochem J. 1986 May;18(5):271–276. doi: 10.1007/BF01676237. [DOI] [PubMed] [Google Scholar]
  34. Ross D. G., Travers H. Infantile presentation of adult-type polycystic kidney disease in a large kindred. J Pediatr. 1975 Nov;87(5):760–763. doi: 10.1016/s0022-3476(75)80303-9. [DOI] [PubMed] [Google Scholar]
  35. Schaffner D. L., Barrios R., Massey C., Bañez E. I., Ou C. N., Rajagopalan S., Aguilar-Cordova E., Lebovitz R. M., Overbeek P. A., Lieberman M. W. Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol. 1993 Apr;142(4):1051–1060. [PMC free article] [PubMed] [Google Scholar]
  36. Schmid P., Schulz W. A., Hameister H. Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science. 1989 Jan 13;243(4888):226–229. doi: 10.1126/science.2911736. [DOI] [PubMed] [Google Scholar]
  37. Shi Y., Glynn J. M., Guilbert L. J., Cotter T. G., Bissonnette R. P., Green D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 1992 Jul 10;257(5067):212–214. doi: 10.1126/science.1378649. [DOI] [PubMed] [Google Scholar]
  38. Sorenson C. M., Rogers S. A., Korsmeyer S. J., Hammerman M. R. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am J Physiol. 1995 Jan;268(1 Pt 2):F73–F81. doi: 10.1152/ajprenal.1995.268.1.F73. [DOI] [PubMed] [Google Scholar]
  39. Surh C. D., Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature. 1994 Nov 3;372(6501):100–103. doi: 10.1038/372100a0. [DOI] [PubMed] [Google Scholar]
  40. Takahashi H., Ueyama Y., Hibino T., Kuwahara Y., Suzuki S., Hioki K., Tamaoki N. A new mouse model of genetically transmitted polycystic kidney disease. J Urol. 1986 Jun;135(6):1280–1283. doi: 10.1016/s0022-5347(17)46074-5. [DOI] [PubMed] [Google Scholar]
  41. Toth L. E., Slawin K. L., Pintar J. E., Nguyen-Huu M. C. Region-specific expression of mouse homeobox genes in the embryonic mesoderm and central nervous system. Proc Natl Acad Sci U S A. 1987 Oct;84(19):6790–6794. doi: 10.1073/pnas.84.19.6790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Trudel M., Chrétien N., D'Agati V. Disappearance of polycystic kidney disease in revertant c-myc transgenic mice. Mamm Genome. 1994 Mar;5(3):149–152. doi: 10.1007/BF00352345. [DOI] [PubMed] [Google Scholar]
  43. Trudel M., D'Agati V., Costantini F. C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int. 1991 Apr;39(4):665–671. doi: 10.1038/ki.1991.80. [DOI] [PubMed] [Google Scholar]
  44. Tsiokas L., Kim E., Arnould T., Sukhatme V. P., Walz G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6965–6970. doi: 10.1073/pnas.94.13.6965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Van Adelsberg J., Chamberlain S., D'Agati V. Polycystin expression is temporally and spatially regulated during renal development. Am J Physiol. 1997 May;272(5 Pt 2):F602–F609. doi: 10.1152/ajprenal.1997.272.5.F602. [DOI] [PubMed] [Google Scholar]
  46. Veis D. J., Sorenson C. M., Shutter J. R., Korsmeyer S. J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 1993 Oct 22;75(2):229–240. doi: 10.1016/0092-8674(93)80065-m. [DOI] [PubMed] [Google Scholar]
  47. Ward C. J., Turley H., Ong A. C., Comley M., Biddolph S., Chetty R., Ratcliffe P. J., Gattner K., Harris P. C. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1524–1528. doi: 10.1073/pnas.93.4.1524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wilkinson D. G., Bailes J. A., Champion J. E., McMahon A. P. A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression. Development. 1987 Apr;99(4):493–500. doi: 10.1242/dev.99.4.493. [DOI] [PubMed] [Google Scholar]
  49. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med. 1995 Jul 6;333(1):18–25. doi: 10.1056/NEJM199507063330104. [DOI] [PubMed] [Google Scholar]
  50. Wyllie A. H., Rose K. A., Morris R. G., Steel C. M., Foster E., Spandidos D. A. Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. Br J Cancer. 1987 Sep;56(3):251–259. doi: 10.1038/bjc.1987.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Zimmerman K. A., Yancopoulos G. D., Collum R. G., Smith R. K., Kohl N. E., Denis K. A., Nau M. M., Witte O. N., Toran-Allerand D., Gee C. E. Differential expression of myc family genes during murine development. 1986 Feb 27-Mar 5Nature. 319(6056):780–783. doi: 10.1038/319780a0. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES